Similar articles

• Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer.

  Tischkowitz M, Eeles R; IMPACT study: Identification of Men with genetic predisposition to Prostate Cancer and its Clinical Treatment collaborators. Tischkowitz M, et al. Lancet. 2003 Jul 5;362(9377):80; author reply 80. doi: 10.1016/S0140-6736(03)13823-8. Lancet. 2003. PMID: 12853213 No abstract available.
• Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.

  Meyer P, Voigtlaender T, Bartram CR, Klaes R. Meyer P, et al. Hum Mutat. 2003 Sep;22(3):259. doi: 10.1002/humu.9174. Hum Mutat. 2003. PMID: 12938098
• Prostate cancer progression and survival in BRCA2 mutation carriers.

  Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H. Tryggvadóttir L, et al. J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. doi: 10.1093/jnci/djm005. Epub 2007 Jun 12. J Natl Cancer Inst. 2007. PMID: 17565157
• Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.

  Swisher E. Swisher E. Curr Womens Health Rep. 2003 Feb;3(1):27-32. Curr Womens Health Rep. 2003. PMID: 12521547 Review.
• Genomic rearrangements in the BRCA1 and BRCA2 genes.

  Mazoyer S. Mazoyer S. Hum Mutat. 2005 May;25(5):415-22. doi: 10.1002/humu.20169. Hum Mutat. 2005. PMID: 15832305 Review.